BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML

Gert Ossenkoppele; Paresh Vyas

doi:https://doi.org/10.1200/JCO.20.01788

BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML

Research output: Contribution to journal › Review article › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	3461-3463
Number of pages	3
Journal	Journal of clinical oncology
Volume	38
Issue number	30
DOIs	https://doi.org/10.1200/JCO.20.01788
Publication status	Published - 20 Oct 2020

Access to Document

https://doi.org/10.1200/JCO.20.01788

Cite this

@article{6d70851e6cca46b7afb9bb12c73b3c08,

title = "BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML",

author = "Gert Ossenkoppele and Paresh Vyas",

note = "Funding Information: P.V. is supported by the Medical Research Council Grant No. MC_UU_12009/11 Blood Cancer UK Specialist Programme Grant No. 13001 and Programme Continuity Grant No. 20005, Wellcome Trust, Blood Cancer UK, and National Institute for Health Research through a Senior Investigator Award and Oxford Comprehensive Biomedical Research Centre. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2020",

month = oct,

day = "20",

doi = "https://doi.org/10.1200/JCO.20.01788",

language = "English",

volume = "38",

pages = "3461--3463",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "30",

}

TY - JOUR

T1 - BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML

AU - Ossenkoppele, Gert

AU - Vyas, Paresh

N1 - Funding Information: P.V. is supported by the Medical Research Council Grant No. MC_UU_12009/11 Blood Cancer UK Specialist Programme Grant No. 13001 and Programme Continuity Grant No. 20005, Wellcome Trust, Blood Cancer UK, and National Institute for Health Research through a Senior Investigator Award and Oxford Comprehensive Biomedical Research Centre. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2020/10/20

Y1 - 2020/10/20

UR - http://www.scopus.com/inward/record.url?scp=85093539386&partnerID=8YFLogxK

U2 - https://doi.org/10.1200/JCO.20.01788

DO - https://doi.org/10.1200/JCO.20.01788

M3 - Review article

C2 - 32730185

SN - 0732-183X

VL - 38

SP - 3461

EP - 3463

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 30

ER -

BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML

Access to Document

Other files and links

Cite this